How is the heart best protected in chronic dialysis patients?: Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patients

Semin Dial. 2014 Jul-Aug;27(4):328-32. doi: 10.1111/sdi.12178. Epub 2014 Feb 5.

Authors

Patrick B Mark¹, Alison H M Taylor, Emily P McQuarrie, Alan G Jardine

Affiliation

¹ Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.

PMID: 24499322
DOI: 10.1111/sdi.12178

No abstract available

Publication types

Review

MeSH terms

Cardiovascular Diseases / etiology
Cardiovascular Diseases / metabolism
Cardiovascular Diseases / prevention & control*
Humans
Kidney Failure, Chronic* / complications
Kidney Failure, Chronic* / metabolism
Kidney Failure, Chronic* / therapy
Mineralocorticoid Receptor Antagonists / therapeutic use*
Receptors, Mineralocorticoid / drug effects
Receptors, Mineralocorticoid / metabolism*
Renal Dialysis*

Substances

Mineralocorticoid Receptor Antagonists
Receptors, Mineralocorticoid